Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Sensus Healthcare
NasdaqCM:SRTS Community
2
Narratives
written by author
1
Comments
on narratives written by author
87
Fair Values set
on narratives written by author
Create a narrative
Sensus Healthcare
Popular
Undervalued
Overvalued
Sensus Healthcare
NA
NateF
Community Contributor
SRTS Market Outlook
Sensus Healthcare, Inc. (NASDAQ: SRTS) specializes in non-invasive treatments for skin conditions, notably through its Superficial Radiation Therapy (SRT) technology.
View narrative
US$13.42
FV
59.9% undervalued
intrinsic discount
20.39%
Revenue growth p.a.
Set as Fair Value
6
users have liked this narrative
0
users have commented on this narrative
40
users have followed this narrative
about 2 months ago
author updated this narrative
Sensus Healthcare
WA
Analyst Price Target
Consensus Narrative from 5 Analysts
Global Expansion And Transdermal Infusion Product Will Strengthen Future Market Presence
Key Takeaways Strategic partnerships and revenue models are driving top-line growth through diversification, increased system placements, and enhanced utilization. Geographic expansion and product innovation, including transdermal infusion development, indicate potential for future revenue growth and diversification.
View narrative
US$11.50
FV
53.2% undervalued
intrinsic discount
20.22%
Revenue growth p.a.
Set as Fair Value
2
users have liked this narrative
0
users have commented on this narrative
20
users have followed this narrative
24 days ago
author updated this narrative
Your Valuation for
SRTS
Sensus Healthcare
Your Fair Value
US$
Current Price
US$5.38
19.7% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-7m
75m
2015
2018
2021
2024
2025
2027
2030
Revenue US$74.8m
Earnings US$11.9m
Advanced
Set as Fair Value